XAIR Stock Analysis: Buy, Sell, or Hold?
XAIR - Beyond Air, Inc. Common Stock
$5.36
-0.20 (-3.60%)
âŧ
5d:
+1.61%
30d:
+1153.8%
90d:
+978.04%
WAIT
LOW Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 13, 2026
3d
Get Alerted When XAIR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: XAIR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: XAIR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: XAIR is currently trading at $5.36, which is considered fair relative to its 30-day fair value range of $2.00 to $6.70.
Technical Outlook: Technically, XAIR is in a strong uptrend. Immediate support is located at $5.02, while resistance sits at $7.74. Short-term momentum is weak, with the stock down 3.6% recently.
Market Sentiment: XAIR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $280.00 (+5123.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XAIR is in a strong uptrend. Immediate support is located at $5.02, while resistance sits at $7.74. Short-term momentum is weak, with the stock down 3.6% recently.
Market Sentiment: XAIR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $280.00 (+5123.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.00 -
$6.70
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
44.7%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.6%)
- BULLISH: Trading 5123.9% below Wall St target ($280.00)
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.00 -
$6.70
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$5.02
Resistance Level
$7.74
Current Trend
Strong Uptrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.01
Wall Street Target
$280.00
(+5123.9%)
Revenue Growth (YoY)
65.5%
Share & Embed Analysis
Last updated: August 09, 2026 6:51 AM ET
Data refreshes hourly during market hours. Next update: 7:51 AM
Data refreshes hourly during market hours. Next update: 7:51 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XAIR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 39 SELL |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 49 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 32 SELL |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 49 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 41 HOLD |
